Parenteral Nutrition Process Management for Newborn and Preterm Infants – A Preliminary Risk Analysis
Isabelle Sommer,1– 4 David Palmero,1 Céline Julie Fischer Fumeaux,5 Pascal Bonnabry,3,4,6 Lucie Bouchoud,6 Farshid Sadeghipour1– 4 1Service of Pharmacy, Lausanne University Hospital, Lausanne, Switzerland; 2Center for Research and Innovation in Clinical Pharmaceutical...
Guardado en:
| Autores principales: | , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/cf0d609285aa4adbb4eadd7a19b632e4 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:cf0d609285aa4adbb4eadd7a19b632e4 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:cf0d609285aa4adbb4eadd7a19b632e42021-12-02T16:54:00ZParenteral Nutrition Process Management for Newborn and Preterm Infants – A Preliminary Risk Analysis1178-203Xhttps://doaj.org/article/cf0d609285aa4adbb4eadd7a19b632e42021-05-01T00:00:00Zhttps://www.dovepress.com/parenteral-nutrition-process-management-for-newborn-and-preterm-infant-peer-reviewed-fulltext-article-TCRMhttps://doaj.org/toc/1178-203XIsabelle Sommer,1– 4 David Palmero,1 Céline Julie Fischer Fumeaux,5 Pascal Bonnabry,3,4,6 Lucie Bouchoud,6 Farshid Sadeghipour1– 4 1Service of Pharmacy, Lausanne University Hospital, Lausanne, Switzerland; 2Center for Research and Innovation in Clinical Pharmaceutical Sciences, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland; 3School of Pharmaceutical Sciences, University of Geneva, Geneva, Switzerland; 4Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, Geneva, Switzerland; 5Clinic of Neonatology, Department Woman Mother Child, Lausanne University Hospital, Lausanne, Switzerland; 6Service of Pharmacy,Geneva University Hospital, Geneva, SwitzerlandCorrespondence: Isabelle Sommer Service of Pharmacy, Lausanne University Hospital, Lausanne, SwitzerlandTel +41 79 556 63 59Email Isabelle.sommer@chuv.chBackground: There are variable practices in the management of the parenteral nutrition (PN) process in hospitals having a neonatal intensive care unit (NICU). In our hospital, PN is prepared partially on the neonatal ward by nurses but also at the central pharmacy by trained pharmacy technicians. A previous study showed a concentration non-conformity of 34% of on-ward PN preparations potentially resulting in under- or overfeeding of the patients.Objective: The objectives were to perform preliminary risk analyses (PRA) in preparation for our hospital’s transition to universal central pharmacy PN compounding.Methods: A working group including pharmacists, neonatologists, nurses, and pharmacy technicians performed two PRA. The risks of 9 management steps of the PN process were identified, evaluated, and quoted. A comparison of the number of risks and their criticality index (CI) was conducted.Results: A total of 36 and 39 risks were identified for PN preparation in the NICU and the pharmacy, respectively. For the NICU, ten risks (28%) had an “acceptable” CI, 15 risks (42%) were “under control” and eleven (31%) were defined as “non-acceptable”. For the pharmacy, 14 risks (36%) had an “acceptable” CI, 19 risks (49%) were “under control” and six (15%) were defined as “non-acceptable”. Risks directly related to the preparation process, including the steps preparation hood, PN preparation and analytical quality control, represented a cumulated CI of 145 for eleven NICU-risks vs 108 for twelve pharmacy risks (− 26%). The implementation of immediate improvement measures, eg, an electronic prescription form, reduces the total CI by 5.7% and 2.2% for the NICU and the pharmacy, respectively.Conclusion: This PRA highlighted the safety differences between PN preparation in the NICU vs the pharmacy at our institution, and facilitated our moving forward with a process change that should improve the care of our neonatal patients. Nevertheless, long-term improvement measures have to be implemented to further reduce risks related to the PN management process.Keywords: parenteral nutrition, drug compounding, risk assessment, standardization, neonatology, preterm infantsSommer IPalmero DFischer Fumeaux CJBonnabry PBouchoud LSadeghipour FDove Medical Pressarticleparenteral nutritiondrug compoundingrisk assessmentstandardizationneonatologypreterm infantsTherapeutics. PharmacologyRM1-950ENTherapeutics and Clinical Risk Management, Vol Volume 17, Pp 497-506 (2021) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
parenteral nutrition drug compounding risk assessment standardization neonatology preterm infants Therapeutics. Pharmacology RM1-950 |
| spellingShingle |
parenteral nutrition drug compounding risk assessment standardization neonatology preterm infants Therapeutics. Pharmacology RM1-950 Sommer I Palmero D Fischer Fumeaux CJ Bonnabry P Bouchoud L Sadeghipour F Parenteral Nutrition Process Management for Newborn and Preterm Infants – A Preliminary Risk Analysis |
| description |
Isabelle Sommer,1– 4 David Palmero,1 Céline Julie Fischer Fumeaux,5 Pascal Bonnabry,3,4,6 Lucie Bouchoud,6 Farshid Sadeghipour1– 4 1Service of Pharmacy, Lausanne University Hospital, Lausanne, Switzerland; 2Center for Research and Innovation in Clinical Pharmaceutical Sciences, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland; 3School of Pharmaceutical Sciences, University of Geneva, Geneva, Switzerland; 4Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, Geneva, Switzerland; 5Clinic of Neonatology, Department Woman Mother Child, Lausanne University Hospital, Lausanne, Switzerland; 6Service of Pharmacy,Geneva University Hospital, Geneva, SwitzerlandCorrespondence: Isabelle Sommer Service of Pharmacy, Lausanne University Hospital, Lausanne, SwitzerlandTel +41 79 556 63 59Email Isabelle.sommer@chuv.chBackground: There are variable practices in the management of the parenteral nutrition (PN) process in hospitals having a neonatal intensive care unit (NICU). In our hospital, PN is prepared partially on the neonatal ward by nurses but also at the central pharmacy by trained pharmacy technicians. A previous study showed a concentration non-conformity of 34% of on-ward PN preparations potentially resulting in under- or overfeeding of the patients.Objective: The objectives were to perform preliminary risk analyses (PRA) in preparation for our hospital’s transition to universal central pharmacy PN compounding.Methods: A working group including pharmacists, neonatologists, nurses, and pharmacy technicians performed two PRA. The risks of 9 management steps of the PN process were identified, evaluated, and quoted. A comparison of the number of risks and their criticality index (CI) was conducted.Results: A total of 36 and 39 risks were identified for PN preparation in the NICU and the pharmacy, respectively. For the NICU, ten risks (28%) had an “acceptable” CI, 15 risks (42%) were “under control” and eleven (31%) were defined as “non-acceptable”. For the pharmacy, 14 risks (36%) had an “acceptable” CI, 19 risks (49%) were “under control” and six (15%) were defined as “non-acceptable”. Risks directly related to the preparation process, including the steps preparation hood, PN preparation and analytical quality control, represented a cumulated CI of 145 for eleven NICU-risks vs 108 for twelve pharmacy risks (− 26%). The implementation of immediate improvement measures, eg, an electronic prescription form, reduces the total CI by 5.7% and 2.2% for the NICU and the pharmacy, respectively.Conclusion: This PRA highlighted the safety differences between PN preparation in the NICU vs the pharmacy at our institution, and facilitated our moving forward with a process change that should improve the care of our neonatal patients. Nevertheless, long-term improvement measures have to be implemented to further reduce risks related to the PN management process.Keywords: parenteral nutrition, drug compounding, risk assessment, standardization, neonatology, preterm infants |
| format |
article |
| author |
Sommer I Palmero D Fischer Fumeaux CJ Bonnabry P Bouchoud L Sadeghipour F |
| author_facet |
Sommer I Palmero D Fischer Fumeaux CJ Bonnabry P Bouchoud L Sadeghipour F |
| author_sort |
Sommer I |
| title |
Parenteral Nutrition Process Management for Newborn and Preterm Infants – A Preliminary Risk Analysis |
| title_short |
Parenteral Nutrition Process Management for Newborn and Preterm Infants – A Preliminary Risk Analysis |
| title_full |
Parenteral Nutrition Process Management for Newborn and Preterm Infants – A Preliminary Risk Analysis |
| title_fullStr |
Parenteral Nutrition Process Management for Newborn and Preterm Infants – A Preliminary Risk Analysis |
| title_full_unstemmed |
Parenteral Nutrition Process Management for Newborn and Preterm Infants – A Preliminary Risk Analysis |
| title_sort |
parenteral nutrition process management for newborn and preterm infants – a preliminary risk analysis |
| publisher |
Dove Medical Press |
| publishDate |
2021 |
| url |
https://doaj.org/article/cf0d609285aa4adbb4eadd7a19b632e4 |
| work_keys_str_mv |
AT sommeri parenteralnutritionprocessmanagementfornewbornandpreterminfantsndashapreliminaryriskanalysis AT palmerod parenteralnutritionprocessmanagementfornewbornandpreterminfantsndashapreliminaryriskanalysis AT fischerfumeauxcj parenteralnutritionprocessmanagementfornewbornandpreterminfantsndashapreliminaryriskanalysis AT bonnabryp parenteralnutritionprocessmanagementfornewbornandpreterminfantsndashapreliminaryriskanalysis AT bouchoudl parenteralnutritionprocessmanagementfornewbornandpreterminfantsndashapreliminaryriskanalysis AT sadeghipourf parenteralnutritionprocessmanagementfornewbornandpreterminfantsndashapreliminaryriskanalysis |
| _version_ |
1718382887895564288 |